The crucial roles of the intrarenal renin-angiotensin system (RAS) in the development and progression of DN have been recognized (5), and traditional RAS inhibitors (RASI), such as angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), are currently considered to be effective treatments for DN. Here, ACE is linked to liver dysplastic nodule.